What every interventional cardiologist should know about new cardiovascular drugs
Summary
Hannah McConkey (UK) talks to cardiologist and pharmacologist Atul Pathak (France) about the important changes in recent drug therapy. They discuss the easy-to-use lipid-lowering PCSK9 inhibitors, and ask should cardiologists now be prescribing the new classes of antidiabetic drugs? The key messages in antithrombotic therapy, and how to manage patients with poor renal function also come under the spotlight.
The content of this video was filmed at EuroPCR 2019: see more videos here…